Multiple sclerosis and Gene mutation identification test positive

Summary:

Gene mutation identification test positive is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Gene mutation identification test positive with Multiple sclerosis. It is created by eHealthMe based on reports of 17 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,089 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Gene mutation identification test positive?

Gene mutation identification test positive is found to be associated with 33 drugs and 135 conditions by eHealthMe. Check the latest studies of Gene mutation identification test positive.



On Jul, 11, 2026

17 people who have Multiple Sclerosis and Gene Mutation Identification Test Positive are studied.

Would you have Gene mutation identification test positive when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Gene Mutation Identification Test Positive *:

  • female: 82.35 %
  • male: 17.65 %

Age of people who have Multiple Sclerosis and experienced Gene Mutation Identification Test Positive *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 25.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 8.33 %

Common co-existing conditions for these people *:

  1. Pain: 1 person, 5.88%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.88%

Common drugs taken by these people *:

  1. Tysabri: 10 people, 58.82%
  2. Avonex: 5 people, 29.41%
  3. Zofran Odt: 1 person, 5.88%
  4. Novantrone: 1 person, 5.88%
  5. Lasix: 1 person, 5.88%
  6. Lioresal: 1 person, 5.88%
  7. Lortab: 1 person, 5.88%
  8. Marinol: 1 person, 5.88%
  9. Methylprednisolone Sodium Succinate: 1 person, 5.88%
  10. Motrin Ib: 1 person, 5.88%

Common symptoms for these people *:

  1. Arteriovenous Fistula: 2 people, 11.76%
  2. Carcinoma In Situ Of Skin: 2 people, 11.76%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 11.76%
  4. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.76%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 11.76%
  6. Weakness: 1 person, 5.88%
  7. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 5.88%
  8. Fall: 1 person, 5.88%
  9. Exposure To Communicable Disease: 1 person, 5.88%
  10. Excoriation (to tear or wear off the skin of): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gene mutation identification test positive?

- Check whether Gene mutation identification test positive is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Gene mutation identification test positive:

All the conditions that are associated with Gene mutation identification test positive:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Gene mutation identification test positive and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: